|
Originally published In Press as doi:10.1074/jbc.M110927200 on December 18, 2001
J. Biol. Chem., Vol. 277, Issue 13, 11392-11400, March 29, 2002
Increased Hexokinase Activity, of Either Ectopic or Endogenous
Origin, Protects Renal Epithelial Cells against Acute
Oxidant-induced Cell Death*
Jane M.
Bryson §,
Platina E.
Coy §,
Kathrin
Gottlob¶,
Nissim
Hay¶, and
R. Brooks
Robey § **
From the Department of Medicine, Section of
Nephrology, Department of Physiology & Biophysics, and
¶ Department of Molecular Genetics, College of Medicine,
University of Illinois, Chicago and § Veterans Affairs
Chicago Health Care System, West Side Division, Chicago, Illinois
60612
Received for publication, November 14, 2001, and in revised form, December 14, 2001
 |
ABSTRACT |
Glucose (Glc) metabolism protects cells against
oxidant injury. By virtue of their central position in both Glc uptake
and utilization, hexokinases (HKs) are ideally suited to contribute to
these effects. Compatible with this hypothesis, endogenous HK activity
correlates inversely with injury susceptibility in individual renal
cell types. We recently reported that ectopic HK expression mimics the
anti-apoptotic effects of growth factors in cultured fibroblasts, but
anti-apoptotic roles for HKs have not been examined in other cell types
or in a cellular injury model. We therefore evaluated HK overexpression
for the ability to mitigate acute oxidant-induced cell death in an
established epithelial cell culture injury model. In parallel, we
examined salutary heparin-binding epidermal growth factor (EGF)-like
growth factor (HB-EGF) treatment for the ability to 1) increase
endogenous HK activity and 2) mimic the protective effects of ectopic
HK expression. Both HK overexpression and HB-EGF increased
Glc-phosphorylating capacity and metabolism, and these changes were
associated with markedly reduced susceptibility to acute
oxidant-induced apoptosis. The uniform Glc dependence of these effects
suggests an important adaptive role for Glc metabolism, and for HK
activity in particular, in the promotion of epithelial cell survival.
These findings also support the contention that HKs contribute to the
protective effects of growth factors.
 |
INTRODUCTION |
Glucose (Glc)1
metabolism plays a critical role in the protection of a variety of
cell types against oxidant-induced cell death (1-9). The mechanisms
underlying these cytoprotective effects are poorly understood, but
contributions by both altered energy metabolism and cellular redox
status have been suggested. Hexokinases (HKs) play a central role in
both the uptake and utilization of Glc by catalyzing the first
committed step of its metabolism, the phosphorylation of Glc to yield
Glc 6-phosphate. By this mechanism, HKs maintain the downhill
concentration gradient that permits facilitated Glc entry into cells.
They also initiate all major pathways of Glc utilization and are
ideally positioned to influence metabolic flux through both the
glycolytic and the pentose phosphate pathways. Glycolytic flux is
intimately linked to cellular energy metabolism, whereas pentose
phosphate pathway flux plays a pivotal role in maintaining the cellular
redox state. In principle, therefore, HK activity may directly
contribute to the salutary effects associated with Glc metabolism in
the setting of oxidative stress.
Three high affinity HK isoforms, HKI, HKII, and HKIII, are expressed in
the mammalian kidney (10). Of these, HKI constitutes the principal
renal isoform and accounts for roughly two-thirds of the total
Glc-phosphorylating capacity of the normal kidney. The remaining HK
activity is equally attributable to the two lower abundance renal
isoforms, HKII and HKIII. Very little is known, however, about the
normal expression, regulation, or function of individual HK isoforms in
specific renal cell types. Cortical HK activity is increased in a
variety of conditions associated with structural or functional
alterations in the kidney (11-14), but the specific cell types and HK
isoforms associated with these changes have not been defined. Given the
substantial proximal tubular composition of the renal cortex, it is
reasonable to assume that this nephron segment contributes
significantly to these changes.
The proximal tubule plays a number of centrally important roles in
normal renal physiology. This nephron segment also exhibits marked
susceptibility to both oxidative and toxic injury in vivo and represents the principal renal cell type affected by a wide variety
of pathophysiologic conditions. Because a general inverse correlation
exists between endogenous HK activity and injury susceptibility in
individual renal cell types (15-18), we hypothesized that HK activity
may constitute an intrinsic cellular protective mechanism and play
important adaptive roles in cellular responses to oxidative stress. To
directly test this hypothesis and to better understand this important
family of enzymes in the kidney, we first examined the functional
consequences of ectopic HK expression in an established cell culture
model of acute oxidant-induced proximal tubule cell injury (19-21). We
then investigated whether changes in endogenous HK activity could
contribute to the well-described salutary effects of growth factors on
this cell type (22). Heparin-binding EGF-like growth factor (HB-EGF)
was specifically selected for study on the basis of its increased renal
expression during recovery from acute ischemic injury (23), as well as
the demonstrated ability of the closely related family member EGF to
ameliorate toxic and ischemic renal injury in vivo (22,
24-26). These findings have led some investigators to propose
protective and/or reparative roles for HB-EGF in the oxidant injury
associated with renal ischemia-reperfusion (22, 23), so we directly
tested this growth factor for the ability to both increase endogenous
proximal tubule cell HK activity and mimic the protective effects of HK
overexpression. In parallel, individual protective effects associated
with either ectopic or endogenous HK activity were specifically
examined for dependence upon the availability of Glc.
 |
EXPERIMENTAL PROCEDURES |
Reagents--
All cell culture reagents, including serum and
media additives, were supplied by Invitrogen (Grand Island, NY). Grade
I yeast Glc 6-phosphate dehydrogenase and a lactate dehydrogenase (LDH) activity detection kit were purchased from Roche Molecular Biochemicals (Indianapolis, IN). The chemical fluorophores
4',6'-diamidino-2-phenylindole (DAPI), propidium iodide (PI), and
YO-PRO-1 were obtained from Molecular Probes (Eugene, OR). All other
reagents, including -NADP, ATP, and recombinant human HB-EGF, were
from Sigma Chemical Co. (St. Louis, MO) unless otherwise specified.
Cell Culture--
Mycoplasma-free
HsPTC2
(Homo
sapiens Proximal
Tubule Cells) were obtained from the American
Type Culture Collection (Rockville, MD) at passage 15. These cells are
clonally derived from normal adult human proximal tubule cells that
have been immortalized by transduction with human papillomavirus (HPV 16) E6 and E7 genes (19). They exhibit both biochemical and morphological features of normal proximal tubule cells in culture (19,
27) and represent an established cell culture model of oxidant-induced
proximal tubule injury (19-21). Cells were routinely grown in
monolayer culture on polystyrene dishes (Falcon, Becton Dickinson,
Franklin Lakes, NJ) or uncoated glass chamber slides (LabTek II, Nalge
Nunc, Naperville, IL). Normal growth medium consisted of standard
Dulbecco's modified Eagle:Ham's F-12 (1:1) medium supplemented with
5% fetal bovine serum as described previously (27) but with the
following modifications: The medium was buffered with 20 mM
HEPES, and the Glc content was reduced to 7.5 mM. Cells were maintained at 37 °C in a humidified 5% CO2
incubator, and all experiments were performed between passages 15 and
30 to minimize the effects of phenotypic variation in continuous
culture. Cells were also routinely serum-deprived for 16-24 h to
induce quiescence prior to testing.
Adenoviral Transgene Delivery and Expression--
Recombinant
replication-deficient adenoviruses expressing HKI (rAd-HKI), the GLUT1
facilitative Glc transporter (rAd-GLUT1), and a -galactosidase
reporter gene (rAd-LacZ) (28) were obtained from Dr. Christopher B. Newgard (University of Texas Southwestern Medical Center, Dallas, TX)
and were used to transfect quiescent HsPTC monolayers as
described previously (29). Ectopic HKI expression was monitored by
coupled enzymatic HK assays (see below), and -galactosidase
expression in paired LacZ-transfected control cells was monitored by a
standard cytochemical method as detailed previously (30).
Susceptibility to oxidant-induced cell death was routinely examined
24 h following transfection, when transgene expression was maximal.
Hexokinase Assays--
Whole cell lysates were
prepared by brief sonication (30-60 J) in ice-cold homogenization
buffer (45 mM Tris-HCl, 50 mM
KH2PO4, 10 mM Glc, 11.1 mM monothioglycerol, 0.5 mM EDTA, 0.2% (v/v)
Triton X-100, pH 8.2), and HK activity was measured as the total
Glc-phosphorylating capacity of fresh lysates using a standard Glc
6-phosphate dehydrogenase-coupled assay as described previously (31,
32) with minor modifications. The final assay mixture consisted of 1 unit/ml Glc 6-phosphate dehydrogenase, 0.5 mg/ml -NADP, 6.7 mM ATP, 7 mM MgCl2, 4 mM Glc, 2.5 mM KH2PO4,
1 mM NaH2PO4, 11.1 mM
monothioglycerol, 0.01% (v/v) Triton X-100, 25 µM EDTA,
and 45 mM Tris-HCl, pH 8.5. Total cellular protein content
was assessed by the method of Bradford (33) using bovine -globulin
(Bio-Rad) as a reference standard, and all data were expressed as
specific HK activity in units per g of total protein, where 1 unit is
defined as that amount of enzyme activity resulting in the coupled
formation of 1 µmol of NADPH per min at 25 °C.
Metabolic Assays--
Glc utilization and lactate production
were evaluated as described previously (31, 32) and were assayed as the
net rates of Glc disappearance and lactate accumulation in the culture
medium, respectively. For these experiments, cells were tested in
normal growth medium containing 7.5 mM Glc and lacking both
serum and phenol red. Where appropriate, medium aliquots were assayed
colorimetrically for both Glc and lactate content. Net cellular
reductive capacity was also monitored using a commercially available
tetrazolium reduction assay (CellTiter 96 AQueous
Non-Radioactive Cell Proliferation Assay, Promega; Madison, WI). This
in situ assay, which relies on the ability of viable cells
to reduce MTS
(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (34)) in the presence of the electron acceptor phenazine ethosulfate, is widely employed to monitor net cellular reductive capacity as an
indicator of both proliferation and viability. Originally attributed to
mitochondrial metabolism (35), it has subsequently been demonstrated
that tetrazolium bioreduction to yield formazan chromophores is
primarily extramitochondrial and largely involves the pyridine
dinucleotides NADH and NADPH (36). It has also been shown that formazan
generation is critically dependent upon both the uptake and continued
metabolism of Glc (37, 38), presumably via the coupled reduction of
pyridine dinucleotides. Thus, chromophore formation will necessarily
reflect both ongoing metabolic activity and oxidative consumption of
reduced nicotinamide cofactor pools. MTS reduction assays were
performed according to the manufacturer's recommendations and were
exploited to monitor net cellular reductive capacity in real-time as
described previously (38).
Acute Oxidative Stress Model--
The oxidative stress
model used for these studies was essentially as described by Zager and
colleagues (19-21) with minor modifications. HsPTC cells
were routinely grown to ~90% confluence in normal growth medium
before serum deprivation overnight to induce quiescence. In
preliminary testing, serum deprivation alone, for periods up to 24 h, was not sufficient to induce apoptosis in these
cells.3 Quiescent cell
monolayers were then exposed to H2O2 at
concentrations up to 10 mM for as long as 3 h at
37 °C in Hanks' balanced salt solution (HBSS) containing
physiologic levels of Glc (5.6 mM).
Cell Viability/Death Assays--
In initial experiments, cell
death was monitored microscopically by the uptake of both YO-PRO-1 (39)
and PI, fluorescent markers of apoptosis and necrosis, respectively.
Quiescent HsPTC monolayers were exposed to
H2O2 (0-10 mM) for up to 3 h
at 37 °C in HBSS containing 1 µM YO-PRO-1 and/or 1.5 µM PI. The cellular uptake of both fluorophores was
monitored, alone and in combination, using a Carl Zeiss LSM 410 laser
scanning confocal microscope system equipped with an argon/krypton
laser as previously described (40), and unstressed control cells were
routinely analyzed in parallel to exclude direct toxic effects of the
fluorophores. The exclusion of both YO-PRO-1 and PI from viable,
non-apoptotic cells makes them useful to screen for cell death in
real-time, but because not all cells are visualized by this method,
additional measures are required for quantitative estimates of cell
death. For this reason, quantitative assessment of apoptosis was
performed under selected conditions by conventional DAPI staining and
cell counting (29, 41). In these experiments, cells were fixed, where
appropriate, by the direct addition of formaldehyde to the medium to a
final concentration of 10% (v/v). Detached cells were allowed to
settle and adhere to the slide before DAPI staining and analysis using
a Zeiss Axioplan 2 fluorescence microscopy system equipped with a
matched ultraviolet light source. Apoptotic cells were manually counted
and expressed as a percentage of the total cell number. At least four
independent fields of ~100 cells were scored for each experimental condition.
Cytolysis Assays--
Plasma membrane integrity was serially
assessed by monitoring cytosolic lactate dehydrogenase (LDH) release
into the culture medium using a commercially available assay kit (Roche
Molecular Biochemicals) per the manufacturer's recommendations. In
brief, LDH activity was colorimetrically assayed in cell-free aliquots of culture supernatants via the coupled enzymatic reduction of a
tetrazolium salt to generate a formazan chromophore. The total releasable pool of cellular LDH activity was always assayed in identical paired cell monolayers following lysis with 1% (v/v) Triton
X-100, and the proportion of the total activity in the supernatant was
taken as an index of the degree of cell lysis.
Statistical Analysis--
All data are presented as the
means ± S.E. for at least three independent experiments.
Statistical comparisons were performed by two-tailed paired
t-testing using a significance level of 95% and StatView
5.0.1 software for Macintosh computers (SAS Institute, Cary, NC).
 |
RESULTS |
H2O2 Decreases Both HsPTC Viability and Net
Cellular Reductive Capacity in a Time- and
Concentration-dependent Manner--
To characterize the
general response of HsPTC to acute oxidative stress,
quiescent cell monolayers were exposed to varying concentrations of
H2O2 (0-10 mM) in the presence of
fluorescent indicators of apoptosis (1 µM YO-PRO-1)
and/or necrosis (1.5 µM PI). H2O2
increased the cellular uptake of both fluorophores in a concentration-
and time-dependent manner, with virtually all cells
exhibiting YO-PRO-1 uptake and nuclear condensation characteristic of
apoptosis within 2 h of exposure to 10 mM
H2O2 (Fig.
1A). PI uptake exhibited
similar H2O2 concentration dependence but
typically lagged behind YO-PRO-1 uptake by 0.5-1.0
h.3 In addition to this
temporal delay, PI uptake by cells incubated with both fluorophores was
observed only in YO-PRO-1-staining apoptotic cells, suggesting the
development of secondary necrotic changes in these cells. Acute
oxidative stress was also associated with marked depression of in
situ tetrazolium bioreduction (Fig. 1B). This effect
was similarly concentration-dependent and was most marked
at H2O2 concentrations associated with
increased early apoptosis (Fig. 1A). Changes in net
cellular reductive capacity, however, uniformly preceded the uptake of
both YO-PRO-1 and PI, which is temporally compatible with roles for
both metabolism and cellular redox status in this model of acute
oxidant-induced cell death.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 1.
H2O2 increases
apoptosis and decreases cellular reductive capacity in a time- and
concentration-dependent manner. A,
confluent HsPTC monolayers were exposed to
H2O2 at the indicated concentrations for up to
2.5 h at 37 °C in HBSS supplemented with 1 µM
YO-PRO-1. Apoptotic cells rendered permeable to YO-PRO-1 are
recognizable by characteristic green fluorescence and nuclear
condensation when excited with the 488-nm line of an argon-krypton
laser. Cells exposed to H2O2 increased YO-PRO-1
in both a time- and concentration-dependent manner.
Propidium iodide (PI) uptake, visualized as red fluorescence when
excited with the 567-nm line of an argon-krypton laser, was similarly
increased, but the cellular uptake of PI was uniformly delayed relative
to that of YO-PRO-1. In fact, PI uptake consistently lagged behind
YO-PRO-1 uptake by as much as 0.5-1.0 h (data not shown). Light
microscopic examination revealed equivalent numbers of attached cells
for all conditions at the completion of the 2.5-h treatment period
above. Treatment times >2.5 h, however, were associated with
progressive cell detachment and morphologic changes associated with
cell death (see below). The representative experiment depicted was
repeated three times with similar results. B,
H2O2 also decreased net cellular reductive
capacity in a concentration-dependent manner, as assessed
by the in situ reduction of the tetrazolium salt MTS to
yield a formazan chromophore. These changes, which were most marked at
concentrations associated with increased YO-PRO-1 uptake, temporally
preceded the apoptosis-associated uptake of this fluorophore. A
representative experiment, performed in triplicate and repeated twice
with identical results, is depicted.
|
|
Adenoviral HKI Transgene Delivery Increases Total HK Activity in a
Titer-dependent Manner--
To directly assess the
functional consequences of primary increases in cellular Glc
phosphorylating capacity, HsPTC were transfected with
recombinant adenoviruses expressing either a -galactosidase reporter
gene (rAd-LacZ) or an HKI transgene. As depicted in Fig. 2A, control adenoviral
transfections using the -galactosidase-expressing vector
(rAd-LacZ) resulted in uniform, titer-dependent
reporter gene expression. HKI overexpression using a matched vector
(rAd-HKI; Fig. 2B) similarly increased total HK activity in
a titer-dependent manner. Basal HK activity (17 ± 1 units/g of protein) in untransfected HsPTC was comparable in
magnitude to that reported previously for both this cell line (27) and
for primary cultures of human proximal tubule cells (42). In paired
cell monolayers, infection with rAd-HKI at a relative multiplicity of
infection (m.o.i.) of ~1 increased total HK activity at
24 h by over 40% (25 ± 2 units/g of protein,
p < 0.001), whereas a 10-fold higher viral titer
increased total HK activity nearly 4-fold (64 ± 7 units/g of
protein, p < 0.001).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 2.
Adenoviral HKI transgene delivery increases
total HK activity in a concentration-dependent manner.
Confluent cell monolayers were routinely transfected with matched
recombinant pJM17-based adenoviruses (28) expressing a
-galactosidase reporter gene (rAd-LacZ) or a rat HKI
transgene (rAd-HKI). As shown in A, transfections
with rAd-LacZ resulted in uniform, titer-dependent reporter
gene expression, with virtually all cells expressing cytochemically
detectable -galactosidase at viral multiplicities-of-infection
(m.o.i.) 1. A representative set of control transfections is
shown. As depicted in B, transfection with rAd-HKI resulted
in similar titer-dependent HKI transgene expression. At an
m.o.i. ~ 1, rAd-HKI increased total HK activity by over 40% at
24 h (*, p < 0.001). Exposure to a 10-fold
greater titer of rAd-HKI (m.o.i. ~ 10) resulted in a corresponding
4-fold increase in total HK activity (*, p < 0.001).
Higher viral titers were associated with much smaller increments in HK
activity and were variably accompanied by evidence of cellular
toxicity, ostensibly due to higher levels of native adenoviral gene
product expression (29).
|
|
Cells Expressing Ectopic HKI Exhibit Decreased
Susceptibility to Acute Oxidant-induced Cell
Death--
-Galactosidase-expressing (+rAd-LacZ), recombinant
HKI-expressing (+rAdHKI), and paired untransfected HsPTC
cell monolayers were acutely exposed to H2O2
over a concentration range (1-10 mM) previously required
to induce rapid oxidant-induced death in both these cells (19-21) and
isolated proximal tubule segments (21, 43). As shown in Fig.
3, cells overexpressing HKI (+rAd-HKI, m.o.i. ~1; lower panels) exhibited improved cell
morphology and attachment, as well as decreased uptake of both YO-PRO-1
and PI, relative to paired untransfected controls (wt; upper
panels) or cells expressing a -galactosidase reporter gene
(+rAd-LacZ, m.o.i. ~1; middle panels) when exposed to 10 mM H2O2 for 3 h. Qualitatively similar effects were observed at lower H2O2
concentrations, but they were temporally delayed and markedly extended
the time frame required for analysis.3 The salutary
benefits of ectopic HK expression were associated with modest increases
in total HK activity (>40%) that were comparable in magnitude to
those previously associated with reduced apoptosis in cultured
fibroblasts following prolonged growth factor withdrawal (29).
Additional protective benefits were not observed at the higher levels
of HK activity associated with higher rAd-HKI titers, so all subsequent
experiments were conducted at comparable functional titers
(i.e. m.o.i. ~1), except where noted. The representative experiment depicted in Fig. 3 was repeated three times with identical results.

View larger version (94K):
[in this window]
[in a new window]
|
Fig. 3.
HsPTC expressing ectopic HKI exhibit
decreased susceptibility to acute oxidant-induced cell death.
Confluent HsPTC monolayers were exposed to 10 mM H2O2 for 3 h in the
presence of both 1 µM YO-PRO-1 and 1 µg/ml PI. Ectopic
HKI expression sufficient to increase total HK activity by >40% (see
Fig. 2B; m.o.i. ~ 1) was associated with marked
cytoprotective benefits. Cells overexpressing HKI (+rAd-HKI)
exhibited improved cell morphology and attachment (left
panels), increased plasma membrane integrity (center
and right panels), and decreased apoptosis (right
panels) when compared with -galactosidase-expressing
(+rAd-LacZ) or untransfected (wt) control cells.
A representative experiment, repeated twice with identical results, is
depicted. The cellular uptake of PI temporally lagged behind that of
YO-PRO-1 and was uniformly observed in YO-PRO-1-containing cells,
consistent with the development of secondary necrotic changes. The
longer incubation times required to observe PI uptake (typically 2.5
h) were frequently associated with increased cell detachment as
shown.
|
|
HK Overexpression Decreases Cytolysis in Both Stressed and
Unstressed HsPTC--
We also monitored the extracellular release of
cytosolic LDH as a marker of plasma membrane integrity. Total cellular
LDH content in these experiments remained stable and was not different in paired stressed and unstressed cells. Basal LDH release by unstressed cells averaged 10 ± 1% of the total cellular LDH
content over 3 h. As depicted in Fig.
4, exposure to 1 mM
H2O2 nearly doubled the rate of LDH release
during this time period, whereas exposure to 10 mM
H2O2 more than trebled this response (*,
p < 0.05). These findings were both temporally and
quantitatively compatible with the observed changes in cellular PI
uptake by oxidant-stressed HsPTC. Ectopic HK expression by
rAd-HKI prevented the increase in LDH release by cells exposed to 1 mM H2O2 in a titer-dependent manner (Fig.
5). Interestingly, HKI overexpression also decreased LDH release by unstressed cells, suggesting small, albeit significant (*, p < 0.05), salutary effects on
basal apoptosis as well.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 4.
H2O2 increases
HsPTC lysis in a concentration-dependent
manner. Acute oxidant-induced cell lysis was monitored as the
release of cytosolic LDH into the culture medium. Basal LDH release by
unstressed cells was consistently ~10% of the total cellular LDH
content over this period and was comparable in magnitude to basal
levels of cell lysis reported for isolated rat proximal tubules (43).
An increase of ~3-fold in LDH release was observed within 3 h in
the presence of 10 mM H2O2, and
intermediate responses were observed in the presence of 1 or 5 mM H2O2 (*, p < 0.02 versus basal).
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
Ectopic HK expression increases cell
viability in both stressed and unstressed HsPTC.
As demonstrated in Fig. 4, total LDH release by cells exposed to 1 mM H2O2 for 3 h ( ) was
nearly 2-fold higher than that associated with paired, unstressed
control cells ( , p < 0.02). However, prior
transfection with rAd-HKI prevented oxidant-induced cytolysis in a
titer-dependent manner and increased cell viability in
unstressed control cells as well (*, p < 0.05 versus paired unstressed controls; , p < 0.05 versus paired oxidant-stressed controls). All data
represent the means ± S.E. for at least three independent
measures, and error bars are depicted were they are larger
than the symbols used to depict the means.
|
|
Ectopic HKI Expression Exerts Anti-apoptotic Effects That Correlate
with Increased Cellular Glc Phosphorylating Capacity--
Apoptotic
cell death was quantitatively assessed in DAPI-stained HsPTC
by microscopic examination and manual counting of condensed and
fragmented nuclei (29, 41). Both stressed (10 mM
H2O2) and unstressed control cell monolayers
were routinely scored for apoptosis in parallel with
-galactosidase-, HKI-, or GLUT1-overexpressing cells. As shown in
Fig. 6A, exposure of untransfected HsPTC to 10 mM H2O2 in the presence of 7.5 mM Glc more than doubled the number of apoptotic cells at
1 h. Ectopic HK expression (+rAd-HKI) largely prevented this
increase (*, p < 0.05), in agreement with the
corresponding decrease in YO-PRO-1 uptake described above. In contrast,
both -galactosidase reporter gene expression (+rAd-LacZ) and
facilitative Glc transporter overexpression (+rAd-GLUT1) failed to
mimic the effects of ectopic HK expression on the fractional rate of
oxidant-induced HsPTC apoptosis. It is pertinent to note, however, that, in individual experiments, GLUT1-overexpressing cells
consistently exhibited oxidant-induced apoptotic rates that were
intermediate between those observed for HKI-overexpressing cells and
-galactosidase-expressing control cells. Pairwise analysis of the
data at 1 h confirmed that apoptosis increased by 209 ± 50%
(p < 0.02 versus unstressed controls) and
206 ± 49% (p < 0.02 versus
unstressed controls) in -galactosidase-expressing and untransfected
control cells, respectively. These responses were indistinguishable
from one another (p = 0.93), whereas apoptosis in
oxidant-stressed HKI-overexpressing cells increased by only 53 ± 12% (p < 0.05 versus oxidant-stressed
-galactosidase-expressing and untransfected controls). The
corresponding response in GLUT1-overexpressing cells (125 ± 30%)
was intermediate between these extremes but never achieved statistical
significance in these studies (p = 0.17 and
p = 0.10 versus -galactosidase-expressing
and untransfected control cells, respectively). As shown in Fig.
6B, total HK activity (17 ± 2 units/g of protein in untransfected HsPTC) was
increased by HKI overexpression in these studies (24 ± 2 units/g
of protein, p = 0.0003) but was not affected by either
-galactosidase reporter gene expression (17 ± 1 units/g of
protein, p = 0.72) or ectopic GLUT1 expression (18 ± 2 units/g of protein, p = 0.26).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
Ectopic HKI expression prevents acute
oxidant-induced apoptosis and increases cellular Glc phosphorylating
capacity. A, exposure of untransfected HsPTC
to 10 mM H2O2 ( ) in the presence
of 7.5 mM Glc rapidly and markedly increased the number
of apoptotic cells. Neither -galactosidase reporter gene
expression (+rAd-LacZ, ) nor facilitative Glc
transporter overexpression (+rAd-GLUT1, ) at comparable
m.o.i. had a significant effect on the fractional rate of apoptosis
in H2O2-stressed cells. In contrast, HKI
overexpression (+rAd-HKI, ) largely prevented this
increase in oxidant-induced apoptosis (*, p < 0.05).
These findings were consistent with the YO-PRO-1 uptake results shown
in Figs. 1A and 3. All data depicted at 0, 0.5, and 1 h
represent the means ± S.E. for at least three independent
experiments. The data at 1.5 h ( ) represent results from a pair
of independent experiments used to define the curves beyond 1 h,
but excluded from statistical analysis because of sample size
limitations. Error bars for all data are shown where they
are larger than the symbols used to depict the means. As shown in
B, the salutary effects of HKI overexpression
(+rAd-HKI) were associated with an increase in total HK
activity (*, p = 0.0003). In contrast, both
-galactosidase reporter gene expression (+rAd-LacZ) and
facilitative Glc transporter overexpression (+rAd-GLUT1),
which failed to mimic the protective effects associated with rAd-HKI
(A), did not increase HsPTC Glc-phosphorylating
capacity (B).
|
|
The Salutary Effects of Ectopic HK Expression Require the
Availability of Glc--
To examine whether the protective effects
associated with increased HK activity depend upon substrate
availability, we specifically examined the ability of rAd-HKI to
mitigate acute oxidant-induced HsPTC apoptosis in both the
presence and absence of Glc. As shown in Fig.
7, Glc removal from the medium during
exposure to 10 mM H2O2 abrogated
the cytoprotective effect of ectopic HKI expression. In addition, the
rate of oxidant-induced apoptosis was actually enhanced in both
untransfected and HKI-overexpressing HsPTC in the absence of
Glc, suggesting intrinsic Glc-dependent protective mechanisms that presumably include endogenous HK activity.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 7.
The salutary effects of ectopic HK expression
require substrate availability. As demonstrated in Fig.
6A, HKI overexpression (+rAd-HKI) prevented
oxidant-induced apoptosis in the presence of 5.6 mM Glc
( ; *, p < 0.03 versus paired
untransfected control cells, ). Glc removal from the medium not only
abrogated the protective effect of HKI overexpression, it enhanced the
rate of oxidant-induced apoptosis in both HKI-overexpressing cells
( ; §, p < 0.04 and **, p = 0.007 versus HKI-overexpressing cells in the presence of Glc, )
and untransfected control cells ( ; , p < 0.03 versus corresponding cells in the presence of Glc, ). In
the absence of Glc, oxidant-induced apoptosis was indistinguishable
between HKI-overexpressing cells ( ) and untransfected cells ( ;
p > 0.69), suggesting the complete dependence of
HK-associated protective effects on substrate availability. All data
represent the means ± S.E. for at least three independent
experiments, with the following exception: Data depicted at 1.5 h
( ) represent results from a pair of independent experiments used to
define the curves beyond 1 h but not included in the statistical
analysis of the data because of sample size limitations. Error
bars are shown where they are larger than the symbols used to
depict the means.
|
|
HB-EGF Increases Endogenous HK Activity and Mimics the
Glc-dependent Effects of Ectopic HK Expression--
To
address the hypothesis that endogenous HK activity could contribute to
the salutary effects of growth factors, we first examined the ability
of HB-EGF to increase endogenous HK activity and Glc metabolism in
HsPTC. In preliminary experiments, HB-EGF increased total HK
activity in a concentration- and time-dependent manner,
with maximal HK induction observed within 12-24 h of exposure to 1
nM HB-EGF (apparent ED50 ~ 0.1 nM). As shown in Fig.
8A, 10 nM HB-EGF
increased HK activity by over 25% (21.0 ± 1.1 versus 16.6 ± 1.1 units/g of protein; p < 0.03) at
24 h, and Fig. 8B demonstrates that these changes were
associated with ~50% net increases in both Glc utilization (3.9 ± 0.2 versus 2.8 ± 0.2 mmol/g of protein/6 h; ,
p < 0.03) and lactate accumulation (6.3 ± 0.5 versus 4.1 ± 0.3 mmol/g of protein/6 h; *,
p < 0.002). We then examined whether these changes
were associated with altered susceptibility to acute oxidant-induced
cell death. In the absence of HB-EGF pretreatment, 10 mM
H2O2 more than doubled the number of apoptotic
cells within 40 min (Fig. 8C; *, p < 0.005 versus unstressed control cells), and these results are
consistent with the corresponding responses depicted in Figs.
6A and 7. In contrast, pretreatment of paired cell
monolayers with 10 nM HB-EGF for 24 h completely
prevented this increase in acute oxidant-induced apoptosis (Fig.
8D; , p = 0.02 and *, p < 0.004 versus time-paired HB-EGF-naïve control
cells). As shown in Fig. 9, the
protective effect of HB-EGF pretreatment was also fully abolished by
the removal of Glc from the media, suggesting similar Glc dependence and a requirement for metabolism. All other factors being equal, the
rates of oxidant-induced apoptosis were uniformly higher in the absence
of Glc, which is compatible with the results presented in Fig. 7 and
suggests intrinsic Glc-dependent protective mechanisms in
these cells.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 8.
HB-EGF pretreatment mimics the effect of
ectopic HK expression. As shown in A, HsPTC
pretreatment with 10 nM HB-EGF increased total HK activity
at 24 h (*, p < 0.03), and, as demonstrated in
B, this increase was temporally associated with net
increases in both Glc utilization and lactate accumulation ( ,
+HB-EGF; , HB-EGF; , p < 0.03 and *,
p < 0.002, respectively). C, in the absence
of HB-EGF pretreatment, 10 mM H2O2
increased apoptosis normally ( ; *, p < 0.005 versus unstressed control cells, ). In D, it
can be appreciated that HB-EGF pretreatment ( ) completely prevented
this acute increase in oxidant-induced apoptosis ( , p = 0.02 and *, p < 0.004 versus
corresponding time-paired HB-EGF-naïve cells; see
C). In contrast, HB-EGF had no corresponding independent
effects on basal apoptosis in unstressed HsPTC ( ).
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 9.
The cytoprotective effects of HB-EGF
pretreatment are also Glc-dependent. To directly
address the substrate dependence of the protective effects of HB-EGF,
we examined HB-EGF-pretreated cells (10 nM × 24 h)
for susceptibility to acute oxidant-induced apoptosis in both the
presence and absence of Glc. Consistent with the results shown in Fig.
8, HB-EGF pretreatment decreased acute oxidant-induced apoptosis in the
presence ( ; *, p < 0.05) but not the absence ( )
of Glc. Rates of apoptosis were uniformly higher in the absence of Glc
( , ) when compared with identical cells with access to
physiologic levels of Glc ( , ), consistent with the presence of
intrinsic Glc-dependent protective mechanisms.
|
|
 |
DISCUSSION |
In this study, we have clearly shown that primary
increases in HK activity, vis-à-vis ectopic
HK expression, are associated with decreased renal epithelial
cell susceptibility to oxidant-induced cell death. In
parallel, we have demonstrated that HB-EGF and associated
increases in endogenous HK activity have similar
cytoprotective benefits. The uniform Glc dependence of these
effects suggests a metabolic requirement for substrate
availability and is compatible with the contention that they
require Glc phosphorylation by HKs. Coupled with our previous
findings (29), these results are also compatible with the
hypothesis that HKs play an important role in the
anti-apoptotic effects of growth factors.
Because cell death cannot be fully defined by, or ascribed to, a
single biochemical parameter, we monitored multiple indices of cell
viability and integrity following severe acute oxidative stress.
Identical results obtained using multiple independent measures
validated the ability of increased HK activity to prevent acute
oxidant-induced cell death. Ectopic HK expression was associated with
improved cell morphology, decreased cell detachment, decreased apoptosis, and reduced cytolysis in
H2O2-stressed cells. Rapid decreases in the net
reductive capacity of HsPTC preceded the appearance of
markers of apoptosis and cell death. As the earliest demonstrable
response to acute oxidative stress, these changes suggest an antecedent
imbalance between reductant consumption and production. Given the
dependence of tetrazolium bioreduction upon Glc metabolism (37,
38),3 they are fully compatible with a role for Glc
metabolism in these responses. Characteristic apoptotic changes also
uniformly preceded the loss of plasma membrane integrity in
oxidant-stressed cells, suggesting that cytolysis may represent a
secondary effect in these cells. These findings are consonant with our
previous demonstration that ectopic HK expression promotes cell
survival by preventing early apoptotic events following growth
factor withdrawal (29). Enhanced oxidant-induced apoptotic
responses in both untransfected and HKI-overexpressing HsPTC
in the absence of Glc are also suggestive of intrinsic
Glc-dependent protective mechanisms that presumably involve
endogenous HK activity. Indirect support for cytoprotective roles for
HKs may also be found in the reported association between HKI
expression and recovery of ventricular function in a rat myocardial infarction model (44).
Although facilitative Glc transporter overexpression failed to fully
mimic the effects of ectopic HK expression, our findings are not
incompatible with previous reports of salutary effects associated with
Glc transporter overexpression (8, 45), and they do not exclude a role
for endogenous Glc transporters in our findings. Major control over
cellular Glc uptake and utilization is shared between both transport
and phosphorylation (46), and because metabolic control may be variably
distributed between these functionally interactive processes under
differing cellular conditions (47), it is likely that Glc transport
plays an important role in our findings. However, the inability of
GLUT1 overexpression to functionally substitute for ectopic HKI
expression clearly suggests that substrate entry alone is not
sufficient to protect cells from acute oxidant-induced cell death.
These findings are compatible with previously demonstrated requirements
for Glc metabolism in cellular recovery from oxidative post-hypoxic
injury (2, 4, 6, 8). Based upon both the present findings and our previous studies in fibroblasts (29), we speculate that the protective
functions of Glc specifically require its phosphorylation by HKs.
The exact mechanisms whereby ectopic HK expression protects
HsPTC against oxidant-induced cell death are not known.
However, HK activity could contribute to these effects in a number of
nonexclusive ways. As a major determinant of reduced glutathione (GSH)
generation (48), increased HK activity could promote metabolic flux
through the pentose phosphate pathway and thereby increase both NADPH generation and the coupled reduction of glutathione (7). These changes
would be predicted to directly and favorably influence cellular redox
status. The association between net cellular reductive capacity and
oxidant-induced apoptosis is consistent with such a possibility, as is
an association between increased cellular GSH content and increased HK
activity.4 The reported
ability of EGF to increase pentose phosphate pathway flux in proximal
tubule cells (49) is also compatible with this possibility and with our
present findings. Alternatively, increased HK activity may
energetically favor cell survival by enhancing glycolytic flux. The
importance of cellular ATP content in cell viability is widely accepted
(6, 50), and Glc plays a major role in the maintenance of intracellular
ATP. The widespread use of Glc removal and glycolytic inhibitors in ATP
depletion models of proximal tubule injury constitutes tacit
acknowledgment of the importance of Glc metabolism to survival in this
cell type. Lastly, HKs, specifically the HKI and HKII isoforms, are
distinguished from all other glycolytic enzymes by their capacity to
physically associate with mitochondria and directly couple the first
committed step of Glc metabolism to oxidative phosphorylation (29,
51-53). Mitochondria play a pivotal role in apoptotic cell death, and we have recently shown that mitochondrial HK association promotes both
mitochondrial integrity and cell survival following growth factor
withdrawal, independent of downstream glycolytic flux (29). Given the
inherent complexities of metabolic regulation, it is possible, and even
likely, that other consequences of metabolism (e.g.
pHi) contribute to the protective effects of Glc. An
exhaustive examination of these individual possibilities, however, is
beyond the scope of the present work and remains for future studies to address.
The exogenous H2O2 concentrations used for
these studies may exceed those anticipated in vivo. They
are, however, comparable in magnitude to those employed previously in
both the characterization of this cell line and its validation as a
cell culture model of oxidant injury (19-21). They are also comparable
to the minimum H2O2 concentrations reported to
consistently induce rapid cell death in isolated rat proximal tubular
segments in the presence of physiologic concentrations of Glc (43).
Because oxidant-induced cell death will necessarily reflect the balance
between incident stress and intrinsic protective mechanisms, it is
reasonable to assume that the observed salutary effects of increased HK
activity under conditions of severe acute oxidative stress would also
have implications for lesser degrees of stress. Our observations of qualitatively similar, albeit temporally delayed, responses to lower
concentrations of H2O2 are compatible with this
inference. It is also important to note that the conditions selected
for study in the present work greatly facilitated the examination of
these effects by increasing the signal-to-noise ratio and by compressing the time frame for analysis, thereby avoiding the confounding pro-apoptotic influence of prolonged culture (>24 h) in
the absence of serum.
In conclusion, we have shown that increased HK activity, of either
ectopic or endogenous origin, is associated with decreased HsPTC susceptibility to oxidant-induced cell death. The
effective changes in HK activity were comparable in magnitude to those
previously shown to mimic the anti-apoptotic effects of growth factors
in cultured fibroblasts (29). They are also similar to reported changes
in endogenous HK activity both in vivo (11-14, 54, 55) and
in a variety of cell culture models (31, 32,
56).5 HB-EGF expression is
increased in a wide variety of renal injury models, including
ischemia-reperfusion injury where both protective and reparative roles
have been proposed for this growth factor (22, 23). It is therefore of
considerable interest that HB-EGF mimicked the cytoprotective effects
of ectopic HK expression and was associated with increased endogenous
HK activity and Glc metabolism. These findings suggest metabolic
adaptations relevant to the study of ischemia-reperfusion injury, as
well as the intriguing possibility that increased HK activity may
contribute to the salutary effects of growth factors in the kidney
(22). Indirect support for this hypothesis may be found in recent
descriptions of Glc-dependent interleukin-3-mediated
hematopoietic cell survival (45, 57, 58) and an associated decrease in
HK expression in these cells following growth factor withdrawal (58).
Although the Glc dependence of other anti-apoptotic effects of growth
factors has not been fully examined, the present work, coupled with our
previous findings (29), could suggest a general role for both HK
activity and Glc metabolism in growth factor-mediated survival in
diverse cell types. As a corollary of these hypotheses, HKs may
constitute potential therapeutic targets to prevent or mitigate acute
oxidant renal injury. Lastly, it would be attractive to speculate that adaptive changes in HK activity in normal cells may have a maladaptive counterpart in cancer cells, where glycolytic capacity is known to
correlate with both proliferative capacity and cell survival. Markedly
increased HK expression and activity are central features of the
classical biochemical phenotype of tumor cells detailed by Warburg (59)
in the early part of the last century. These changes also constitute
the principal biochemical basis for the use of positron emission
tomographic imaging of fluorodeoxyglucose uptake to detect tumor
metastases (60). Taken together, it is reasonable to postulate that
increased HK activity may contribute to the ability of a wide range of
cell types to evade programmed cell death. Thus, our findings not only
suggest mechanisms whereby growth factors may exert their salutary
effects on acute oxidant injury but also have specific physiologic,
pathophysiologic, and possibly therapeutic implications.
 |
ACKNOWLEDGEMENTS |
We thank Dr. A. Katzen (Department of
Molecular Genetics, University of Illinois at Chicago) for the use of
the Zeiss Axioplan 2 fluorescence microscopy system employed in these studies.
 |
FOOTNOTES |
*
This work was supported by grants-in-aid from the National
Kidney Foundation of Illinois (to R. B. R.) and the American Heart Association of Metropolitan Chicago (to R. B. R.), as well as by a
United States Department of Veterans Affairs Merit Review Award (to
R. B. R.) and National Institutes of Health Grant AG-16927 (to
N. H.). Portions of this work were presented in preliminary form at
the 6th Annual AstraZeneca Cardiovascular Young Investigators' Forum,
August 19, 2000, in Quebec City, Quebec, Canada and at the 33rd Annual
Meeting of the American Society of Nephrology, October 14, 2000, in
Toronto, Ontario, Canada.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: Dept. of Medicine,
Section of Nephrology, University of Illinois at Chicago College of
Medicine (M/C 793), 820 South Wood St., Rm. 418W Clinical Sciences North, Chicago, IL 60612-7315. Tel.: 312-569-7249; Fax
312-996-7378; E-mail: RBRobey@uic.edu.
Published, JBC Papers in Press, December 18, 2001, DOI 10.1074/jbc.M110927200
2
Originally designated HK-2 cells, this
nomenclature is not used in the present work to avoid confusion with
the HKII isoform.
4
Robey, R. B., Ma, J., Santos, A. V. P.,
Noboa, O. A., Coy, P. E., and Bryson, J. M. (January 8, 2002)
J. Biol. Chem. DOI 10.1074/jbc.M111722200.
5
Coy, P. E., Taneja, N., Lee, I., Hecquet, C.,
Bryson, J. M., and Robey, R. B. (2002) Am. J. Physiol.,
in press (DOI 10.1152/ajprenal.00093.2001).
3
J. M. Bryson and R. B. Robey, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
Glc, glucose;
DAPI, 4',6'-diamidino-2-phenylindole;
EGF, epidermal growth factor;
HB-EGF, heparin-binding EGF-like growth factor;
HBSS, Hanks' balanced
salt solution;
HK, hexokinase;
HsPTC, Homo
sapiens proximal tubule cells;
LDH, lactate dehydrogenase;
m.o.i., multiplicity of infection;
MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium;
PI, propidium iodide;
GLUT1, glucose transporter 1;
rAd, recombinant adenovirus;
HKI, hexokinase I;
wt, wild-type;
GSH, reduced glutathione.
 |
REFERENCES |
| 1.
|
Neely, J. R.,
and Grotyohann, L. W.
(1984)
Circ. Res.
55,
816-824[Abstract/Free Full Text]
|
| 2.
|
Hattori, H.,
and Wasterlain, C. G.
(1990)
Ann. Neurol.
28,
122-128[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Kelleher, J. A.,
Chan, P. H.,
Chan, T. Y. Y.,
and Gregory, G. A.
(1993)
Stroke
24,
855-863[Abstract/Free Full Text]
|
| 4.
|
Schaefer, S.,
Prussel, E.,
and Carr, L. J.
(1995)
J. Mol. Cell. Cardiol.
27,
2167-2176[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Allen, C. B.,
and White, C. W.
(1998)
Am. J. Physiol.
274,
L159-L164[Abstract/Free Full Text]
|
| 6.
|
Saikumar, P.,
Dong, Z.,
Patel, Y.,
Hall, K.,
Hopfer, U.,
Weinberg, J. M.,
and Venkatachalam, M. A.
(1998)
Oncogene
17,
3401-3415[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Tian, W.-N.,
Braunstein, L. D.,
Apse, K.,
Pang, J.,
Rose, M.,
Tian, X.,
and Stanton, R. C.
(1999)
Am. J. Physiol.
276,
C1121-C1131[Abstract/Free Full Text]
|
| 8.
|
Malhotra, R.,
and Brosius, F. C., III
(1999)
J. Biol. Chem.
274,
12567-12575[Abstract/Free Full Text]
|
| 9.
|
Moley, K. H.,
and Mueckler, M. M.
(2000)
Apoptosis
5,
99-105[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Grossbard, L.,
and Schimke, R. T.
(1966)
J. Biol. Chem.
241,
3546-3560[Abstract/Free Full Text]
|
| 11.
|
Dubach, U. C.,
and Recant, L.
(1960)
J. Clin. Invest.
39,
1364-1371[Medline]
[Order article via Infotrieve]
|
| 12.
|
Anderson, J. W.,
and Stowring, L.
(1973)
Am. J. Physiol.
224,
930-936
|
| 13.
|
Steer, K. A.,
Sochor, M.,
Gonzalez, A.-M.,
and McLean, P.
(1982)
FEBS Lett.
150,
494-498[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Sochor, M.,
Kunjara, S.,
and McLean, P.
(1988)
Horm. Metabol. Res.
20,
676-681[Medline]
[Order article via Infotrieve]
|
| 15.
|
Schmidt, U.,
Marosvari, I.,
and Dubach, U. C.
(1975)
FEBS Lett.
53,
26-28[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Vandewalle, A.,
Wirthensohn, G.,
Heidrich, H.-G.,
and Guder, W. G.
(1981)
Am. J. Physiol.
240,
F492-F500
|
| 17.
|
Lawrence, G. M.,
and Trayer, I. P.
(1984)
Histochem. J.
16,
697-708[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Preller, A.,
and Wilson, J. E.
(1992)
Arch. Biochem. Biophys.
294,
482-492[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Ryan, M. J.,
Johnson, G.,
Kirk, J.,
Fuerstenberg, S. M.,
Zager, R. A.,
and Torok-Storb, B.
(1994)
Kidney Int.
45,
48-57[Medline]
[Order article via Infotrieve]
|
| 20.
|
Zager, R. A.,
and Burkhart, K.
(1997)
Kidney Int.
51,
728-738[Medline]
[Order article via Infotrieve]
|
| 21.
|
Zager, R. A.,
and Burkhart, K. M.
(1998)
Kidney Int.
53,
1661-1672[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Hammerman, M. R.,
Safirstein, R.,
Harris, R. C.,
Toback, F. G.,
and Humes, H. D.
(2000)
Am. J. Physiol.
279,
F3-F11
|
| 23.
|
Homma, T.,
Sakai, M.,
Cheng, H. F.,
Yasuda, T.,
Coffey, R. J. J.,
and Harris, R. C.
(1995)
J. Clin. Invest.
96,
1018-1025[Medline]
[Order article via Infotrieve]
|
| 24.
|
Humes, H. D.,
Cieslinski, D. A.,
Coimbra, T. M.,
Messana, J. M.,
and Galvao, C.
(1989)
J. Clin. Invest.
84,
1757-1761[Medline]
[Order article via Infotrieve]
|
| 25.
|
Coimbra, T. M.,
Cieslinski, D. A.,
and Humes, H. D.
(1990)
Am. J. Physiol.
259,
F438-F443[Abstract/Free Full Text]
|
| 26.
|
Norman, J. T.,
Tsau, Y.-K.,
Bacay, A.,
and Fine, L. G.
(1990)
Clin. Sci.
78,
445-450[Medline]
[Order article via Infotrieve]
|
| 27.
|
Racusen, L. C.,
Monteil, C.,
Sgrignoli, A.,
Lucskay, M.,
Marouillat, S.,
Rhim, J. G. S.,
and Morin, J.-P.
(1997)
J. Lab. Clin. Med.
129,
318-329[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Becker, T. C.,
Noel, R. J.,
Coats, W. S.,
Gómez-Foix, A. M.,
Alam, T.,
Gerard, R. D.,
and Newgard, C. B.
(1994)
Methods Cell Biol.
43,
161-189
|
| 29.
|
Gottlob, K.,
Majewski, N.,
Kennedy, S.,
Kandel, E.,
Robey, R. B.,
and Hay, N.
(2001)
Genes Dev.
15,
1406-1418[Abstract/Free Full Text]
|
| 30.
|
Robey, R. B.,
Osawa, H.,
Printz, R. L.,
and Granner, D. K.
(1996)
BioTechniques
20,
40-42[Medline]
[Order article via Infotrieve]
|
| 31.
|
Robey, R. B., Ma, J.,
and Santos, A. V. P.
(1999)
Am. J. Physiol.
277,
F742-F749[Abstract/Free Full Text]
|
| 32.
|
Robey, R. B.,
Raval, B. J., Ma, J.,
and Santos, A. V. P.
(2000)
Kidney Int.
57,
2308-2318[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Barltrop, J. A.,
Owen, T. C.,
Cory, A. H.,
and Cory, J. G.
(1991)
Bioorg. Med. Chem. Lett.
1,
611-614[CrossRef]
|
| 35.
|
Slater, T. F.,
Sawyer, B.,
and Sträuli, U.
(1963)
Biochim. Biophys. Acta
77,
383-393[Medline]
[Order article via Infotrieve]
|
| 36.
|
Berridge, M. V.,
and Tan, A. S.
(1993)
Arch. Biochem. Biophys.
303,
474-482[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Vistica, D. T.,
Skehan, P.,
Scudiero, D.,
Monks, A.,
Pittman, A.,
and Boyd, M. R.
(1991)
Cancer Res.
51,
2515-2520[Abstract/Free Full Text]
|
| 38.
|
Segu, V. B. G., Li, G.,
and Metz, S. A.
(1998)
Metabolism
47,
824-830[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Idziorek, T.,
Estaquier, J., De,
Bels, F.,
and Ameisen, J. C.
(1995)
J. Immunol. Meth.
185,
249-258[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Robey, R. B.,
Ruiz, O.,
Santos, A. V. P., Ma, J.,
Kear, F.,
Wang, L.-J., Li, C.-J.,
Bernardo, A. A.,
and Arruda, J. A. L.
(1998)
Biochemistry
37,
9894-9901[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Kennedy, S. G.,
Wagner, A. J.,
Conzen, S. D.,
Jordán, J.,
Bellacosa, A.,
Tsichlis, P. N.,
and Hay, N.
(1997)
Genes Dev.
11,
701-713[Abstract/Free Full Text]
|
| 42.
|
Courjault-Gautier, F.,
Chevalier, J.,
Abbou, C. C.,
Chopin, D. K.,
and Toutain, J. H.
(1995)
J. Am. Soc. Nephrol.
5,
1949-1963[Abstract/Free Full Text]
|
| 43.
|
Zager, R. A.
(1992)
J. Clin. Invest.
90,
711-719[Medline]
[Order article via Infotrieve]
|
| 44.
|
Yonekura, K.,
Eto, Y.,
Yokoyama, I.,
Matsumoto, A.,
Sugiura, S.,
Monomura, S.,
Kirimoto, T.,
Hayashi, Y.,
Omata, M.,
and Aoyagi, T.
(2000)
Basic Res. Cardiol.
95,
343-348[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Plas, D. R.,
Talapatra, S.,
Edinger, A. L.,
Rathmell, J. C.,
and Thompson, C. B.
(2001)
J. Biol. Chem.
276,
12041-12048[Abstract/Free Full Text]
|
| 46.
|
Kashiwaya, Y.,
Sato, K.,
Tsuchiya, N.,
Thomas, S.,
Fell, D. A.,
Veech, R. L.,
and Passonneau, J. V.
(1994)
J. Biol. Chem.
269,
25502-25514[Abstract/Free Full Text]
|
| 47.
|
Srere, P.
(1994)
Trends Biochem. Sci.
19,
519-520[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Kurata, M.,
Suzuki, M.,
and Agar, N. S.
(2000)
Comp. Haematol. Int.
10,
59-67
|
| 49.
|
Stanton, R. C.,
and Seifter, J. L.
(1988)
Am. J. Physiol.
254,
C267-C271[Abstract/Free Full Text]
|
| 50.
|
Lieberthal, W.,
Menza, S. A.,
and Levine, J. S.
(1998)
Am. J. Physiol.
274,
F315-F327[Abstract/Free Full Text]
|
| 51.
|
BeltrandelRio, H.,
and Wilson, J. E.
(1991)
Arch. Biochem. Biophys.
286,
183-194[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
BeltrandelRio, H.,
and Wilson, J. E.
(1992)
Arch. Biochem. Biophys.
299,
667-677
|
| 53.
|
BeltrandelRio, H.,
and Wilson, J. E.
(1992)
Arch. Biochem. Biophys.
299,
116-124[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Braithwaite, S. S.,
Palazuk, B.,
Colca, J. R.,
Edwards, C. W., III,
and Hofmann, C.
(1995)
Diabetes
44,
43-48[Abstract]
|
| 55.
|
Allen, C. B.,
Guo, X.-L.,
and White, C. W.
(1998)
Am. J. Physiol.
274,
L320-L329[Abstract/Free Full Text]
|
| 56.
|
Riddle, S. R.,
Ahmad, A.,
Ahmad, S.,
Deeb, S. S.,
Makki, M.,
Schneider, B. K.,
Allen, C. B.,
and White, C. W.
(2000)
Am. J. Physiol.
278,
L407-L416[Abstract/Free Full Text]
|
| 57.
|
Kan, O.,
Baldwin, S. A.,
and Whetton, A. D.
(1994)
J. Exp. Med.
180,
917-923[Abstract/Free Full Text]
|
| 58.
|
Vander Heiden, M. G.,
Plas, D. R.,
Rathmell, J. C.,
Fox, C. J.,
Harris, M. H.,
and Thompson, C. B.
(2001)
Mol. Cell. Biol.
21,
5899-5912[Abstract/Free Full Text]
|
| 59.
|
Warburg, O.
(1956)
Science
123,
309-314[Free Full Text]
|
| 60.
|
Muzi, M.,
Freeman, S. D.,
Burrows, R. C.,
Wiseman, R. W.,
Link, J. M.,
Krohn, K. A.,
Graham, M. M.,
and Spence, A. M.
(2001)
Nuclear Med. Biol.
28,
107-116[CrossRef]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Miyamoto, M. Rubio, and M. A. Sussman
Nuclear and mitochondrial signalling Akts in cardiomyocytes
Cardiovasc Res,
May 1, 2009;
82(2):
272 - 285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Abu-Hamad, H. Zaid, A. Israelson, E. Nahon, and V. Shoshan-Barmatz
Hexokinase-I Protection against Apoptotic Cell Death Is Mediated via Interaction with the Voltage-dependent Anion Channel-1: MAPPING THE SITE OF BINDING
J. Biol. Chem.,
May 9, 2008;
283(19):
13482 - 13490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Sun, S. Shukair, T. J. Naik, F. Moazed, and H. Ardehali
Glucose Phosphorylation and Mitochondrial Binding Are Required for the Protective Effects of Hexokinases I and II
Mol. Cell. Biol.,
February 1, 2008;
28(3):
1007 - 1017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Moin, M. Panteva, and S. Jameel
The Hepatitis E Virus Orf3 Protein Protects Cells from Mitochondrial Depolarization and Death
J. Biol. Chem.,
July 20, 2007;
282(29):
21124 - 21133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kim, J.-H. Lim, C. S. Ahn, K. Park, G. T. Kim, W. T. Kim, and H.-S. Pai
Mitochondria-Associated Hexokinases Play a Role in the Control of Programmed Cell Death in Nicotiana benthamiana
PLANT CELL,
September 1, 2006;
18(9):
2341 - 2355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Biju, Y. Akai, N. Shrimanker, and V. H. Haase
Protection of HIF-1-deficient primary renal tubular epithelial cells from hypoxia-induced cell death is glucose dependent
Am J Physiol Renal Physiol,
December 1, 2005;
289(6):
F1217 - F1226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. da-Silva, A. Gomez-Puyou, M. T. de Gomez-Puyou, R. Moreno-Sanchez, F. G. De Felice, L. de Meis, M. F. Oliveira, and A. Galina
Mitochondrial Bound Hexokinase Activity as a Preventive Antioxidant Defense: STEADY-STATE ADP FORMATION AS A REGULATORY MECHANISM OF MEMBRANE POTENTIAL AND REACTIVE OXYGEN SPECIES GENERATION IN MITOCHONDRIA
J. Biol. Chem.,
September 17, 2004;
279(38):
39846 - 39855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Taneja, P. E. Coy, I. Lee, J. M. Bryson, and R. B. Robey
Proinflammatory interleukin-1 cytokines increase mesangial cell hexokinase activity and hexokinase II isoform abundance
Am J Physiol Cell Physiol,
August 1, 2004;
287(2):
C548 - C557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Majewski, V. Nogueira, R. B. Robey, and N. Hay
Akt Inhibits Apoptosis Downstream of BID Cleavage via a Glucose-Dependent Mechanism Involving Mitochondrial Hexokinases
Mol. Cell. Biol.,
January 15, 2004;
24(2):
730 - 740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Rathmell, C. J. Fox, D. R. Plas, P. S. Hammerman, R. M. Cinalli, and C. B. Thompson
Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival
Mol. Cell. Biol.,
October 15, 2003;
23(20):
7315 - 7328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Robey
Caveat experimentor: reporting expression profiling data involving multiple, functionally redundant isoforms
J. Leukoc. Biol.,
September 1, 2003;
74(3):
307 - 308.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-S. Belzacq, H. L. A. Vieira, F. Verrier, G. Vandecasteele, I. Cohen, M.-C. Prevost, E. Larquet, F. Pariselli, P. X. Petit, A. Kahn, et al.
Bcl-2 and Bax Modulate Adenine Nucleotide Translocase Activity
Cancer Res.,
January 15, 2003;
63(2):
541 - 546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Robey, J. Ma, A. V. P. Santos, O. A. Noboa, P. E. Coy, and J. M. Bryson
Regulation of Mesangial Cell Hexokinase Activity and Expression by Heparin-binding Epidermal Growth Factor-like Growth Factor. EPIDERMAL GROWTH FACTORS AND PHORBOL ESTERS INCREASE GLUCOSE METABOLISM VIA A COMMON MECHANISM INVOLVING CLASSIC MITOGEN-ACTIVATED PROTEIN KINASE PATHWAY ACTIVATION AND INDUCTION OF HEXOKINASE II EXPRESSION
J. Biol. Chem.,
April 19, 2002;
277(17):
14370 - 14378.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|